September 2022

ShanX Medtech is selected to join the Pole Position by Techleap

ShanX Medtech has been chosen to join the Pole Position alongside other impact-driven, high-potential Dutch startups that are working relentlessly to improve patient care by bringing much-needed innovations to the market. About Techleap: helps quantify and accelerate the tech ecosystem of the Netherlands. Creating the optimal climate for tech...

ShanX Medtech a step closer to market with the Eurostars

Hundreds of millions of people suffer from Urinary Tract Infections (UTIs) every year worldwide. With the majority of UTIs stemming from a bacterial infection, the treatment thereof is straightforward: an antibiotic prescription. But for doctors quickly determining which antibiotic is effective for each patient is challenging. ShanX Medtech is...

June 2022

ShanX Medtech receives the MIT feasibility study 2022

ShanX Medtech is awarded the MIT- Zuid Feasibility Study Subsidy for Growth, Sustainability and Innovative Economy. This project focuses on the investigation and analysis of the potential of a novel medical technological platform applied for testing of antimicrobial resistance, with the aim of supporting decision making by objectively and rationally...

May 2022

April 2022

March 2022

February 2022

January 2022

December 2021